Title
Category
Credits
Event date
Cost
Colorectal Cancer: Epidemiology, Risk Factors, and Screening Strategies - SPOC
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.25 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Lisa M. Gangarosa, MD provides an overview of epidemiologic trends in colorectal cancer (CRC) modifiable and non modifiable risk factors for CRC, and screening strategies for CRC.
Where the Rubber Meets the Road: Community-Inclusive Interventions to Achieve Equity in Cancer Care - SPOC
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Samuel Cykert, MD, and Christina Yongue, MPH, MCHES, describe the long-lasting racial disparities in breast and lung cancer care, and some of the root causes for these inequities. Participants will learn how a community-academic-medical partnership addressed these disparities by designing system-change interventions based on antiracism principles.
Cancer Pathology: How Diagnosis Drives Treatment - SPOC
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Yuri Fedoriw, MD, provides a general background of cancer pathology and tissue diagnosis. The development of testing methods and their application will be discussed, as will the limitations and challenges of cancer classification.
Role of Specialty Pharmacy - SPOC
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Sonali Acharya, PharmD. will explain the role of specialty pharmacies. We will discuss accreditation requirements for specialty pharmacies, process to determine which medications are considered specialty and specifically the benefits of a healthcare system specialty pharmacy.
Cancer Prevention in Adolescence: How Do We Make a Difference? - SPOC
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.25 ASRT
  • 1.00 ODS
  • 1.25 NCPD/CNE
  • 1.00 Participation
$0.00
This course explores two ways to protect today's adolescents from a future cancer diagnosis: HPV vaccination and alcohol use prevention. For each topic, we will examine the latest evidence on cancer risk, address common misconceptions about risk reduction, and preview UNC-based research to advance prevention science in partnership with parents and primary care professionals.
Cancers of Unknown Primary and the UNC Undiagnosed Cancer Clinic - SPOC
  • Advanced Practice Provider
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.25 NCPD/CNE
  • 1.00 Participation
$0.00
Jonathan Sorah, MD, will describes the work-up, characterization, and treatment of cancers of unknown primary and also present data/successes of our undiagnosed cancer clinic and future plans.
GVHD: An Overview of Graft vs Host Disease Post Hematopoietic Stem Cell Transplant - SPOC
  • Advanced Practice Provider
  • 1.00 Participation
$0.00
Megan McElfresh, PA-C, provides an overview of the pathophysiology, diagnosis, prevention, and treatment of graft vs host disease post hematopoietic stem cell transplant.
CAR-T 101: Overview of CAR-T Therapy and Management of Toxicities - SPOC
  • Advanced Practice Provider
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Megan McElfresh, PA-C, will review chimeric antigen receptor therapy, associated side effects, and the treatment or prevention of side effects.
Cancer Related Pain Management from a Palliative Care Perspective - SPOC
  • Patient Centered Care
  • 1.00 Participation
$0.00
Cindy Kelly, FNP-BC, ACHPN, and Vineeta Rao, PharmD, BCPS, review opioid and nonopioid treatment options for cancer-related pain. Their presentation addresses patients with cancer and substance use disorder and also cancer patients that are in remission, but who still present with persistent pain.
Demystifying Molecular-Based Tests in Head and Neck Cancers - SPOC
  • Research to Practice
  • 1.00 Participation
$0.00
Siddharth Sheth, DO, MPH, will provide a brief overview of clinical factors relevant to head and neck cancers and basic management. Themain focus will be the current use of technologies that aid with the diagnosis, treatment selection, and monitoring of patientswith head and neck cancers. This includes next generation sequencing assays for DNA sequencing, RNA sequencing, andcirculating tumor DNA. The goal of the presentation is for providers to be comfortable with ordering and basic interpretation ofthese tests.

Pages